On receiving news of a health concern there is an immediate thirst for knowledge to understand the condition, the care, and treatment options available.
As a healthcare professional assesses the health status of a person, it may be decided that prescribing a therapeutic drug is the best course of action. These treatments are assigned systematically, not randomly, to achieve an outcome goal. A much smaller number of healthcare professionals may discuss the opportunity for a person to participate in a clinical trial to find new and improved ways to treat, prevent or diagnose different illnesses. Clinical trials generally seek to isolate the pure treatment effect and do so by eliminating or balancing people across comparison groups. These care options are mainly assigned randomly.
In this episode, Jeremy Brody, Head of Global Strategy at Cerner Enviza, discusses when and how industry leaders are embracing both clinical research and real-world data to make care and treatments decisions.